EnteroMedics (ETRM) Reports Q1 Loss of $1.27

EnteroMedics (NASDAQ: ETRM) reported Q1 EPS of ($1.27), versus ($0.94) reported last year. Revenue for the quarter came in at $40 thousand, versus $72 thousand reported last year.

On March 31, 2017, the Company\'s cash, cash equivalents and short-term investments totaled $18.7 million.

For earnings history and earnings-related data on EnteroMedics (ETRM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Reading (RDI) Tops Q2 EPS by 4c